The effect of long-acting somatostatin analogues on the uptake of [ 177 Lu]Lu-HA-DOTATATE.
Chayenne H A M VeermanHinke SiebingaDaphne M V de Vries-HuizingMargot E T TesselaarJeroen J M A HendrikxMarcel P M StokkelElse A AalbersbergPublished in: European journal of nuclear medicine and molecular imaging (2023)
Lu]Lu-HA-DOTATATE in tumour lesions 24 h post-injection. Uptake in healthy liver parenchyma significantly decreases after lanreotide administration prior to PRRT, while uptake in healthy spleen tissue significantly decreases with both octreotide and lanreotide administration.
Keyphrases